Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.
Saglio G; Kim DW; Issaragrisil S; le Coutre P; Etienne G; Lobo C; Pasquini R; Clark RE; Hochhaus A; Hughes TP; Gallagher N; Hoenekopp A; Dong M; Haque A; Larson RA; Kantarjian HM; The New England Journal Of Medicine, 2010, vol. 362, issue 24, p 2251, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation